Biopharmaceutical CMO Global Market Report 2022: Ukraine-Russia War Impact

Publish Date: Dec 2022

Report Code: TBR3562A

Publisher: TBRC (Publisher)

Single User License: $5000

Explore Our Services

Already a member? Login here.

Report Highlights

Including: 1) By Product: Biologics; Biosimilars
2) By Source: Mammalian; Non-Mammalian
3) By Service: Manufacturing; Fill And Finish Operations; Analytical And QC Studies; Packaging
Covering: Lonza Group AG; Fujifilm Diosynth Biotechnologies U.S.A., Inc.; Thermo Fisher Scientific, Inc.; Samsung BioLogics; WuXi Biologics

Biopharmaceutical CMO Global Market Report 2022: Ukraine-Russia War Impact from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global biopharmaceutical cmo market.

This report focuses on biopharmaceutical cmo market which is experiencing strong growth. The report gives a guide to the biopharmaceutical cmo market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Assessment of Russia – War Impact on agriculture, energy and mineral commodities supply and their direct and indirect impact on the market analyzed in the report.
  • Impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel format.

Description:
Where is the largest and fastest growing market for the biopharmaceutical cmo? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Biopharmaceutical CMO market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider biopharmaceutical cmo market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Our forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of covid 19 on supply chains and consumption patterns.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The biopharmaceutical cmo market section of the report gives context. It compares the biopharmaceutical cmo market with other segments of the biopharmaceutical cmo market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, biopharmaceutical cmo indicators comparison.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2021-2031
Units considered $ Billion
Segments covered By Product, By Source, By Service
Industry covered Healthcare Services
Regions covered Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Countries covered Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA
Companies studied
  • Lonza Group AG
  • WuXi Biologics
  • Fujifilm Diosynth Biotechnologies U.S.A., Inc.
  • Thermo Fisher Scientific, Inc.
  • Samsung BioLogics

Scope

Markets Covered:

  • By Product: Biologics; Biosimilars
  • By Source: Mammalian; Non-Mammalian
  • By Service: Manufacturing; Fill And Finish Operations; Analytical And QC Studies; Packaging

Companies Mentioned: Lonza Group AG; Fujifilm Diosynth Biotechnologies U.S.A., Inc.; Thermo Fisher Scientific, Inc.; Samsung BioLogics; WuXi Biologics

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global Historic Market Growth, 2016-2021, $ Billion
  • Table 2 : Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Table 3 : Global Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 4 : Global Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 5 : Global Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 6 : Global Biopharmaceutical CMO Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7 : Global Biopharmaceutical CMO Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8 : Asia-Pacific, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9 : Asia-Pacific, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10 : China, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11 : China, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 12 : India, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 13 : India, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 14 : Japan, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 15 : Japan, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 16 : Australia, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 17 : Australia, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 18 : Indonesia, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 19 : Indonesia, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 20 : South Korea, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 21 : South Korea, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 22 : Western Europe, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 23 : Western Europe, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 24 : UK, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 25 : UK, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 26 : Germany, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 27 : Germany, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 28 : France, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 29 : France, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 30 : Eastern Europe, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 31 : Eastern Europe, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 32 : Russia, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 33 : Russia, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 34 : North America, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 35 : North America, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 36 : USA, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 37 : USA, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 38 : South America, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 39 : South America, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 40 : Brazil, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 41 : Brazil, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 42 : Middle East, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 43 : Middle East, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 44 : Africa, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 45 : Africa, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 46 : Lonza Group AG Financial Performance
  • Table 47 : Fujifilm Diosynth Biotechnologies U.S.A., Inc Financial Performance
  • Table 48 : Thermo Fisher Scientific, Inc Financial Performance
  • Table 49 : Samsung BioLogics Financial Performance
  • Table 50 : WuXi Biologics Financial Performance
  • Figure 1 : Global Historic Market Growth, 2016-2021, $ Billion
  • Figure 2 : Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Figure 3 : Global Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 4 : Global Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 5 : Global Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 6 : Global Biopharmaceutical CMO Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7 : Global Biopharmaceutical CMO Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8 : Asia-Pacific, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9 : Asia-Pacific, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 10 : China, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 11 : China, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 12 : India, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 13 : India, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 14 : Japan, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 15 : Japan, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 16 : Australia, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 17 : Australia, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 18 : Indonesia, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 19 : Indonesia, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 20 : South Korea, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 21 : South Korea, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 22 : Western Europe, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 23 : Western Europe, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 24 : UK, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 25 : UK, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 26 : Germany, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 27 : Germany, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 28 : France, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 29 : France, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 30 : Eastern Europe, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 31 : Eastern Europe, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 32 : Russia, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 33 : Russia, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 34 : North America, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 35 : North America, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 36 : USA, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 37 : USA, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 38 : South America, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 39 : South America, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 40 : Brazil, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 41 : Brazil, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 42 : Middle East, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 43 : Middle East, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 44 : Africa, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 45 : Africa, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 46 : Lonza Group AG Financial Performance
  • Figure 47 : Fujifilm Diosynth Biotechnologies U.S.A., Inc Financial Performance
  • Figure 48 : Thermo Fisher Scientific, Inc Financial Performance
  • Figure 49 : Samsung BioLogics Financial Performance
  • Figure 50 : WuXi Biologics Financial Performance

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Biopharmaceutical CMO Global Market Report 2022: Ukraine-Russia War Impact